Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
about
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytesVogt-Koyanagi-Harada syndrome - current perspectives.Influence of molecular genetics in Vogt-Koyanagi-Harada disease.Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmiaGender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia.Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.Wide-field fluorescein and indocyanine green angiography findings in the eyes with Vogt-Koyanagi-Harada disease.Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease.The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.Late onset acute Vogt-Koyanagi-Harada syndrome-challenges on the way.Chronic Recurrent Vogt–Koyanagi–Harada Disease and Development of ‘Sunset Glow Fundus’ Predict Worse Retinal Sensitivity
P2860
Q26752297-EE21F6B3-9E94-40BB-8183-15889EA3F1E4Q28072882-41CA4095-112D-4217-8703-2375205FC24EQ33929571-33D81FC5-5062-406D-94A0-F3D5754C7532Q36750361-8904F519-5ABD-402A-A882-A637BCDCF6FAQ37661279-97624936-E212-4434-8744-5CE0B8D8A3E6Q37830790-9C2B659F-0E59-4AA3-8B4F-972D1143919FQ39008824-FC0D510E-1496-4947-BFA5-24084A0EACBCQ40972896-F1B44406-7657-490D-9027-27CE4BD2B047Q41162044-D3A5C151-F731-4C3F-84F6-EECA735B2442Q41614992-51E65DD8-6735-4D7F-AB97-5BDFA9082980Q43469154-DA252A15-1356-4F2E-B744-B7B42C7D27F9Q47654494-52C50579-6DC1-43D5-92AB-1D4457FBB64BQ50230399-511FE3EE-F610-4299-8AF7-15C7D987FD0CQ50490823-7C6F54AC-F387-4E3F-AF1D-B96323F87CFFQ50746452-5D93D9ED-E065-468D-9141-154B7C0363D9Q53033802-A74EFB35-7C5D-4D2B-8ED1-E371F5C9E48FQ55373402-4FB9B9F3-6B14-4283-B85F-4F2E388AB6E1Q57584157-D3654803-B06A-42C4-8F6D-6C0D933C074C
P2860
Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@en
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@nl
type
label
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@en
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@nl
prefLabel
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@en
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@nl
P2093
P2860
P356
P1433
P1476
Effects of the duration of ini ...... Vogt-Koyanagi-Harada disease.
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2008.89
P577
2008-03-28T00:00:00Z
P5875
P6179
1002842461